1. Home
  2. LION vs MIRM Comparison

LION vs MIRM Comparison

Compare LION & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$8.99

Market Cap

2.4B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$80.05

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LION
MIRM
Founded
1997
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
3.4B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
LION
MIRM
Price
$8.99
$80.05
Analyst Decision
Buy
Strong Buy
Analyst Count
10
11
Target Price
$9.11
$92.45
AVG Volume (30 Days)
2.5M
802.1K
Earning Date
02-05-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,858,000,000.00
$471,794,000.00
Revenue This Year
N/A
$53.78
Revenue Next Year
$22.30
$19.91
P/E Ratio
N/A
N/A
Revenue Growth
21.18
53.66
52 Week Low
$5.55
$36.88
52 Week High
$9.24
$81.70

Technical Indicators

Market Signals
Indicator
LION
MIRM
Relative Strength Index (RSI) 76.68 67.61
Support Level $8.21 $63.23
Resistance Level $8.75 $66.77
Average True Range (ATR) 0.42 3.70
MACD 0.08 1.62
Stochastic Oscillator 89.41 84.91

Price Performance

Historical Comparison
LION
MIRM

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: